cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Charles River Laboratories International
8 own
6 watching
Current Price
$201.58
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
10,317.27M
52-Week High
52-Week High
262
52-Week Low
52-Week Low
181.22
Average Volume
Average Volume
0.19M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
48.7805
iconMarket Capitalization10,317.27M
icon52-Week High262
icon52-Week Low181.22
iconAverage Volume0.19M
iconDividend Yield--
iconP/E Ratio48.7805
What does the Charles River Laboratories International do?
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and development services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening preclinical drug candidates comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for identification of a druggable target through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. This segment also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs and chickens used in the manufacture of live viruses. The company serves pharmaceutical and biotechnology companies, contract research organizations, agricultural and chemical companies, life science and veterinary medicine companies, contract manufacturing organizations, medical device companies, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Read More
How much money does Charles River Laboratories International make?
News & Events about Charles River Laboratories International.
Globe Newswire
1month ago
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Alico, Inc. (NASDAQ: ALCO) Johnson Fistel, LLP is investigating potential claims on behalf of Alico, Inc. ("Alico" or the "Company") (NASDAQ: ALCO) against certain of its officers and directors. If you are a current, long-term shareholder of Alico holding ...
Globe Newswire
1month ago
SAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) -- Charles River Laboratories International, Inc. Johnson Fistel, LLP is investigating potential claims on behalf of Charles River Laboratories International, Inc. (NYSE: CRL) against certain of its officers and directors. If you are a current long-term ...
Globe Newswire
1month ago
NEW YORK, April 17, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fox Corporation (NASDAQ: FOX, FOXA), Charles River Laboratories International, Inc. (NYSE: CRL), Provident Bancorp, Inc. (NASDAQ: ...
Globe Newswire
1month ago
LOS ANGELES, April 14, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Charles River Laboratories International, Inc. (Charles River or the Company) (NYSE: CRL) on behalf of investors concerning the Companys possible violations of federal securities laws. If ...
Globe Newswire
1month ago
LOS ANGELES, April 14, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Charles River Laboratories International, Inc. (Charles River or the Company) (NYSE: CRL) investors concerning the Companys ...
Frequently Asked Questions
Frequently Asked Questions
What is Charles River Laboratories International share price today?
plus_minus_icon
Can Indians buy Charles River Laboratories International shares?
plus_minus_icon
How can I buy Charles River Laboratories International shares from India?
plus_minus_icon
Can Fractional shares of Charles River Laboratories International be purchased?
plus_minus_icon
What are the documents required to start investing in Charles River Laboratories International stocks?
plus_minus_icon
What is today’s traded volume of Charles River Laboratories International?
plus_minus_icon
What is today’s market capitalisation of Charles River Laboratories International?
plus_minus_icon
What is the 52-Week High and Low Range of Charles River Laboratories International?
plus_minus_icon
What percentage is Charles River Laboratories International down from its 52-Week High?
plus_minus_icon
What percentage is Charles River Laboratories International up from its 52-Week Low?
plus_minus_icon
Current Price
$201.58
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00